Vera Days Payables Outstanding vs Book Value Per Share Analysis
| VERA Stock | USD 22.57 0.04 0.18% |
Vera Therapeutics financial indicator trend analysis is much more than just breaking down Vera Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vera Therapeutics is a good investment. Please check the relationship between Vera Therapeutics Days Payables Outstanding and its Book Value Per Share accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.
Days Payables Outstanding vs Book Value Per Share
Days Payables Outstanding vs Book Value Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vera Therapeutics Days Payables Outstanding account and Book Value Per Share. At this time, the significance of the direction appears to have pay attention.
The correlation between Vera Therapeutics' Days Payables Outstanding and Book Value Per Share is -0.75. Overlapping area represents the amount of variation of Days Payables Outstanding that can explain the historical movement of Book Value Per Share in the same time period over historical financial statements of Vera Therapeutics, assuming nothing else is changed. The correlation between historical values of Vera Therapeutics' Days Payables Outstanding and Book Value Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Payables Outstanding of Vera Therapeutics are associated (or correlated) with its Book Value Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value Per Share has no effect on the direction of Days Payables Outstanding i.e., Vera Therapeutics' Days Payables Outstanding and Book Value Per Share go up and down completely randomly.
Correlation Coefficient | -0.75 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Days Payables Outstanding
Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most indicators from Vera Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vera Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.At present, Vera Therapeutics' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 664.2 M, whereas Tax Provision is forecasted to decline to 800.00.
Vera Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Vera Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vera Therapeutics fundamental ratios Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 54.6M | 83.7M | 131.4M | 175.5M | 655.7M | 688.5M | |
| Short Long Term Debt Total | 2K | 4.9M | 31.3M | 53.7M | 54.6M | 57.4M | |
| Other Current Liab | 1.5M | 6.3M | 8.3M | 8.7M | 16.2M | 17.0M | |
| Total Current Liabilities | 2.4M | 7.7M | 25.6M | 22.3M | 25.4M | 15.5M | |
| Total Stockholder Equity | (89.3M) | 69.6M | 76.9M | 101.7M | 577.2M | 606.0M | |
| Net Debt | (53.7M) | (74.8M) | (83.4M) | 8.0M | (38.0M) | (39.9M) | |
| Retained Earnings | (91.4M) | (124.1M) | (213.1M) | (309.1M) | (461.3M) | (438.2M) | |
| Accounts Payable | 909K | 1.4M | 12.0M | 11.1M | 7.7M | 6.1M | |
| Cash | 53.7M | 79.7M | 114.7M | 45.7M | 92.6M | 71.4M | |
| Non Current Assets Total | 293K | 1.2M | 5.7M | 3.5M | 4.5M | 3.1M | |
| Non Currrent Assets Other | 293K | 344K | 506K | 471K | 131K | 124.5K | |
| Other Assets | 293K | 344K | 455K | 1.0 | 0.9 | 0.86 | |
| Cash And Short Term Investments | 53.7M | 79.7M | 114.7M | 160.7M | 640.9M | 672.9M | |
| Common Stock Shares Outstanding | 3.7M | 21.3M | 26.6M | 42.7M | 55.3M | 28.1M | |
| Short Term Investments | 86.0 | 867K | 71.2M | 115.0M | 548.2M | 575.6M | |
| Liabilities And Stockholders Equity | 54.6M | 83.7M | 131.4M | 175.5M | 655.7M | 688.5M | |
| Non Current Liabilities Total | 141.5M | 6.5M | 28.9M | 51.6M | 53.2M | 43.0M | |
| Capital Lease Obligations | 2K | 0.0 | 6.5M | 3.8M | 4.0M | 2.6M | |
| Other Current Assets | 505K | 2.9M | 11.0M | 11.3M | 6.6M | 6.0M | |
| Other Stockholder Equity | 2.1M | 277.4M | 290.2M | 410.5M | 1.0B | 1.1B | |
| Total Liab | 143.9M | 14.2M | 54.5M | 73.9M | 78.5M | 74.6M | |
| Net Invested Capital | (89.3M) | 74.5M | 101.7M | 151.6M | 627.8M | 659.2M | |
| Total Current Assets | 54.3M | 82.5M | 125.7M | 172.0M | 651.2M | 683.8M | |
| Accumulated Other Comprehensive Income | (139.6M) | (83.7M) | (224K) | 251K | 393K | 412.7K | |
| Net Working Capital | 51.9M | 74.8M | 100.1M | 149.7M | 625.8M | 657.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vera Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vera Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vera Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vera Therapeutics Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vera Therapeutics. If investors know Vera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vera Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vera Therapeutics is measured differently than its book value, which is the value of Vera that is recorded on the company's balance sheet. Investors also form their own opinion of Vera Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vera Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vera Therapeutics' market value can be influenced by many factors that don't directly affect Vera Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vera Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vera Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vera Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.